Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Mar;68(2):99-101.

How do these 3 diabetes agents compare in reducing mortality?

Jennifer Martini  1 , Catherine L Coe  1 , Anne Mounsey  1
Affiliations
Comment

How do these 3 diabetes agents compare in reducing mortality?

Jennifer Martini et al. J Fam Pract. 2019 Mar.

Abstract

A meta-analysis reveals that there may be advantages associated with SGLT-2 inhibitors and GLP-1 agonists that are not associated with DPP-4 inhibitors.

PubMed Disclaimer

Comment on

References

    1. Zheng S, Roddick A, Aghar-Jaffar R, et al. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis. JAMA. 2018;319:1580–1591. - PMC - PubMed
    1. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017.
    1. American Diabetes Association. Standards of medical care in diabetes2019. Diabetes Care. 2019;42(suppl 1):S1-S193.
    1. National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. www.nice.org.uk/guidance/ng28. Published December 2015. Updated May 2017. Accessed March 1, 2019.
    1. Garber A, Abrahamson M, Barzilay J, et al. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm2018 Executive Summary. Endocr Pract. 2018;24:91–120. - PubMed

Publication types